Literature DB >> 6135926

Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer.

M Baum, D M Brinkley, J A Dossett, K McPherson, J S Patterson, R D Rubens, F G Smiddy, B A Stoll, A Wilson, J C Lea, D Richards, S H Ellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6135926     DOI： 10.1016/s0140-6736(83)90406-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  24 in total

Review 1.  Contribution of randomised controlled trials to understanding and management of early breast cancer.

Authors:  M Baum; J Houghton
Journal:  BMJ       Date:  1999-08-28

2.  Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.

Authors:  Xiaonan Hou; Fei Huang; Luciana F Macedo; Sean C Harrington; Karen A Reeves; Ann Greer; Friedrich Graf Finckenstein; Angela Brodie; Marco M Gottardis; Joan M Carboni; Paul Haluska
Journal:  Cancer Res       Date:  2011-10-31       Impact factor: 12.701

Review 3.  Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

4.  Lost in translation: can we afford to miss the trees for the forest?

Authors:  Stephen R Hammes; Carol A Lange
Journal:  Horm Cancer       Date:  2014-08       Impact factor: 3.869

5.  Survey of treatment of primary breast cancer in Great Britain.

Authors:  J L Craven
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

6.  Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.

Authors:  A J Wilson; M Baum; D M Brinkley; J A Dossett; K McPherson; J S Patterson; R D Rubens; F G Smiddy; B A Stoll; D Richards
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

7.  Mastectomy or conservation: the patient's choice.

Authors:  M Baum; L Fallowfield; A Hall
Journal:  BMJ       Date:  1988-12-10

8.  Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.

Authors:  Penn Muluhngwi; Abirami Krishna; Stephany L Vittitow; Joshua T Napier; Kirsten M Richardson; Mackenzie Ellis; Justin L Mott; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2016-12-13       Impact factor: 8.679

Review 9.  Current status of chemotherapy of breast cancer.

Authors:  A Coates
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

10.  Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status.

Authors:  C Rose; H T Mouridsen; S M Thorpe; J Andersen; M Blichert-Toft; K W Andersen
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.